Alkermes plc. — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2018-06-07

Reporting Person: Hopkinson Craig C. (SVP, Med Dev/Med Affairs, CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-07	Ordinary Shares	M	1250	—	Acquired	1250	Direct
2018-06-07	Ordinary Shares	F	369	$48.30	Disposed	881	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-07	Restricted Stock Unit Award	$0	M	1250	Disposed		Ordinary Shares (1250)	Direct

Footnotes

F1: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 6/7/18.